The Role of Dysbiosis in Cardiovascular, Pulmonary and Hematological Complications During HIV Infection (R01)

The summary for the The Role of Dysbiosis in Cardiovascular, Pulmonary and Hematological Complications During HIV Infection (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
The Role of Dysbiosis in Cardiovascular, Pulmonary and Hematological Complications During HIV Infection (R01): The purpose of this Funding Opportunity Announcement (FOA) is to invite basic research project grant applications for HIV Microbiome Centers to perform investigations on the role of HIV-induced dysbiosis and how this imbalance may induce and/or contribute to the occurrence of heart, lung, or blood (HLB) co-morbidities in HIV positive individuals. This FOA will support mechanistic studies that will use in vitro, in vivo, ex vivo, and in silico models applied to HIV research. The goal is to provide the critical basic science foundation to guide early translational approaches to understanding HIV-related HLB conditions in adults and children. This FOA also encourages multidisciplinary collaborations among scientists in a wide range of disciplines including (but not limited to), cardiology, pulmonology, hematology, immunology, '-omic' sciences, infectious disease, microbiology, biotechnology, and bioinformatics.
Federal Grant Title: The Role of Dysbiosis in Cardiovascular, Pulmonary and Hematological Complications During HIV Infection (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Other
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-17-017
Type of Funding: Information not provided
CFDA Numbers: 327489, 327487, 327490, 327488, 327491, 327510
CFDA Descriptions: National Center on Sleep Disorders Research; Cardiovascular Diseases Research; Lung Diseases Research; Blood Diseases and Resources Research; Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
Current Application Deadline: Nov 8, 2016
Original Application Deadline: Nov 8, 2016
Posted Date: Jul 11, 2016
Creation Date: Jul 11, 2016
Archive Date: Dec 9, 2016
Total Program Funding: $2,495,000
Maximum Federal Grant Award: $310,000
Minimum Federal Grant Award: none
Expected Number of Awards: 5
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Information not provided
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-017.html
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405